Discovery	NNP
and	CC
validation	NN
of	IN
extracellular/circulating	VBG
microRNAs	NNS
during	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
disease	NN
progression	NN
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
fibrosing	NN
interstitial	JJ
lung	NN
disease	NN
of	IN
unknown	JJ
etiology	NN
that	WDT
is	VBZ
currently	RB
untreatable	JJ
.	.

In	IN
this	DT
study	NN
we	PRP
aim	VBP
to	TO
characterize	VB
the	DT
potential	NN
of	IN
extracellular/circulating	VBG
microRNAs	NNS
(	(
miRNAs	NNS
)	)
in	IN
serum	NN
as	IN
biomarkers	NNS
for	IN
IPF	NN
.	.

METHODS	NNS
:	:
Total	JJ
serum	NN
RNAs	NNS
were	VBD
isolated	VBN
from	IN
serum	NN
from	IN
healthy	JJ
control	JJ
subjects	NNS
(	(
n	NN
=	JJ
12	CD
)	)
,	,
rapid	JJ
progressive	JJ
(	(
n	NN
=	JJ
12	CD
)	)
and	CC
slowly	RB
progressive	JJ
IPF	NN
patients	NNS
(	(
n	NN
=	JJ
12	CD
)	)
.	.

Serum	NN
RNA	NN
was	VBD
analyzed	VBN
by	IN
using	VBG
TaqMan	NNP
microRNA	NN
assays	NNS
containing	VBG
probes	NNS
for	IN
366	CD
human	JJ
miRNAs	NNS
,	,
and	CC
selected	VBN
findings	NNS
were	VBD
validated	VBN
with	IN
quantitative	JJ
RT-PCR	NN
.	.

Target	NN
prediction	NN
and	CC
pathway	NN
analysis	NN
on	IN
the	DT
significant	JJ
differential	JJ
miRNAs	NNS
were	VBD
performed	VBN
using	VBG
DIANA-mirPath	NN
.	.

RESULTS	NNS
:	:
We	PRP
found	VBD
47	CD
significantly	RB
differentially	RB
expressed	VBN
serum	NN
miRNAs	NNS
(	(
p	NN
<	JJR
0.05	CD
)	)
in	IN
rapid	JJ
progressive	JJ
or	CC
slowly	RB
progressive	JJ
IPF	NN
patients	NNS
compared	VBN
to	TO
healthy	JJ
controls	NNS
,	,
including	VBG
21	CD
up-regulated	VBN
miRNAs	NNS
and	CC
26	CD
down-regulated	VBD
miRNAs	NNS
.	.

Bioinformatic	JJ
analysis	NN
by	IN
DIANA-mirPath	NN
demonstrated	VBD
that	IN
53	CD
KEGG	NN
biological	JJ
processes	NNS
were	VBD
significantly	RB
enriched	JJ
(	(
p	NN
<	JJR
0.05	CD
,	,
FDR	NNP
corrected	VBN
)	)
among	IN
differentially	RB
expressed	VBN
serum	NN
miRNAs	NNS
,	,
including	VBG
TGF-beta	NN
signaling	NN
pathway	NN
(	(
p	NN
<	JJR
0.0001	CD
)	)
,	,
MAPK	NN
signaling	NN
pathway	NN
(	(
p	NN
<	JJR
0.0001	CD
)	)
,	,
PI3K-Akt	NN
signaling	NN
pathway	NN
(	(
p	NN
<	JJR
0.0001	CD
)	)
,	,
Wnt	NN
signaling	NN
pathway	NN
(	(
p	NN
<	JJR
0.0001	CD
)	)
,	,
HIF-1	NN
signaling	NN
pathway	NN
(	(
p	NN
<	JJR
0.0001	CD
)	)
,	,
Regulation	NN
of	IN
actin	NN
cytoskeleton	NN
(	(
p	NN
<	JJR
0.0001	CD
)	)
,	,
Jak-STAT	JJ
signaling	NN
pathway	NN
(	(
p	NN
<	JJR
0.0001	CD
)	)
,	,
Notch	NN
signaling	NN
pathway	NN
(	(
p	NN
<	JJR
0.0001	CD
)	)
,	,
and	CC
Cytokine-cytokine	NN
receptor	NN
interaction	NN
(	(
p	NN
=	JJ
0.0062	CD
)	)
.	.

We	PRP
further	RB
validated	VBD
six	CD
miRNAs	NNS
(	(
miR-21	NN
,	,
miR-199a-5p	NN
,	,
miR-200c	NN
,	,
miR-31	NN
,	,
let-7a	NN
,	,
and	CC
let-7d	NN
)	)
for	IN
further	JJ
validation	NN
using	VBG
an	DT
independent	JJ
cohort	NN
of	IN
20	CD
rapid	JJ
progressive	JJ
IPF	NN
,	,
24	CD
slowly	RB
progressive	JJ
IPF	NN
patients	NNS
and	CC
20	CD
healthy	JJ
controls	NNS
.	.

In	IN
agreement	NN
with	IN
the	DT
preliminary	JJ
data	NNS
from	IN
miRNA	NN
assay	NN
,	,
miR-21	NN
,	,
miR-199a-5p	NN
,	,
and	CC
miR-200c	NN
were	VBD
significantly	RB
increased	VBN
in	IN
serums	NNS
of	IN
IPF	NN
patients	NNS
while	IN
miR-31	NN
,	,
let-7a	NN
,	,
and	CC
let-7d	NN
were	VBD
significantly	RB
under	IN
expressed	VBN
in	IN
serums	NNS
of	IN
IPF	NN
patients	NNS
compared	VBN
to	TO
healthy	JJ
controls	NNS
.	.

CONCLUSIONS	NNS
:	:
These	DT
studies	NNS
demonstrated	VBD
that	IN
extracellular/circulating	VBG
miRNAs	NNS
in	IN
serum	NN
could	MD
be	VB
potentially	RB
served	VBN
as	IN
novel	JJ
regulators	NNS
influencing	VBG
disease	NN
progression	NN
of	IN
IPF	NN
.	.

